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Introduction
The Board of Pharmacy Specialties (BPS) offers the following definition for ambulatory care pharmacy practice, which was developed by a joint task force of the American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP), and the
American College of Clinical Pharmacy (ACCP):
Ambulatory care pharmacy practice is the provision of integrated, accessible health care services by pharmacists who are accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community. This is accomplished through direct patient care and medication management for ambulatory patients, long-term relationships, coordination of care, patient advocacy, wellness and health promotion, triage and referral, and patient education and self-management. The ambulatory care pharmacists may work in both an institutional and community-based clinic involved in direct care of a diverse patient population. 1 Several clear tenets frame the practice of ambulatory care pharmacy: (1) comprehensive medication management within integrated health systems, community pharmacies, and standalone clinical practices; (2) a growing work force of qualified and board-certified clinical pharmacists; (3) a growing emphasis on specialty and subspecialty training across ambulatory care practice settings; and (4) demonstrated improvement in health and care outcomes for patients in ambulatory care settings. Overall, this pharmaceutical care framework demonstrates a firm commitment from the profession to take accountability for health outcomes. 
Historical successes since the 1960s
The 1960s. Ambulatory care pharmacy practice sprang from humble beginnings.
Transformative changes in the pharmacy profession in the 1960s resulted in increased documentation of the economic and human benefits derived from optimizing medication use in the U.S. health system. Ultimately, this refocused efforts toward reducing medication-related morbidity and mortality, and shifted energy away from the product and transaction-based business of pharmacy toward patient-centered care.
One of the first documented examples of patient medication profile use within a community pharmacy practice setting was in 1960 in Berryville, Virginia. Eugene White was a pharmacist who transformed his drugstore into the first known office-based pharmacy practice. 3 In 1962, Albert Ripley, a pharmacist at the Indian Hospital in Crow Agency, Montana, started filling patients' prescriptions based on medical record information instead of paper prescriptions. This was eventually adopted as a best practice by the Indian Health Service (IHS), which subsequently incorporated private consultation offices in most IHS facilities where pharmacists could assess patients and provide medication counseling. described a multi-institutional pharmacy system that was divided into inpatient and ambulatory care practices. Clinical services, research, and educational programs were integrated across settings to address the mission of providing quality services and support programs.
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The 1990s. The 1990s saw similar gains as the previous decades. In 1990, the Office of the Inspector General of the Department of Health and Human Services reviewed available clinical services in community pharmacy settings as part of a larger effort to reduce the incidence of adverse drug events (ADEs) among older adults. Sponsored by the Health Care Financing Administration (now known as the Centers for Medicare & Medicaid Services, or CMS), the report found that "clinical pharmacy services add value to care for both institutionalized and ambulatory patients," and that "such value includes not only improvements in clinical outcomes and enhanced patient compliance, but also reductions in healthcare utilization costs associated with adverse drug reactions." 10 In 1994, an ASHP survey of federal hospital systems documented widespread ambulatory care pharmacy services, including pharmacist-managed drug clinics. Settings included Air Force, Navy, Public Health Service, and Department of Veterans Affairs hospitals. This was the first landscape survey of pharmacy in federal health systems, and it concluded that most settings offered comprehensive pharmacy systems, including clinical services as well as drug product distribution.
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In 1996, the Asheville Project was implemented in collaboration with the North Carolina Center for Pharmaceutical Care, the APhA Foundation, the North Carolina Pharmaceutial Association, and the city of Asheville, among others. Twelve community pharmacies contracted with the city of Asheville to provide diabetes management for city employees as part of a pilot project, with widely publicized success. 12 In 1998, Carter and colleagues initiated a long-term study designed to assess the impact of ambulatory care clinical pharmacy services within selected VA medical centers. In the years that followed, multiple high-impact findings resulted from this work, including identification of risk factors for drug-related problems, development of a chronic disease indicator score, and estimates of the total clinical and economic impact of ambulatory care pharmacy services. [13] [14] [15] [16] In 1999, ASHP and APhA jointly developed standards and learning objectives for accreditation of community pharmacy residency training. This enabled accreditation of such programs through the ASHP Commission on Credentialing. In their joint petition to BPS in 2008, leaders from ACCP, APhA, and ASHP highlighted continued opportunities for ambulatory care pharmacists to improve care for patients with chronic conditions, the costs of which exceeded 75% of the $2 trillion U.S. annual health expenditures. 20 Because medications-and medication management-play a critical role in the management of chronic diseases regardless of setting, the need for more ambulatory care clinical pharmacy services is quite evident. Moreover, such services reduce the potential for common medication-related problems, including prescribing and administration errors, nonadherence, and inappropriate use. Ambulatory care pharmacists are optimally positioned to provide comprehensive medication management for patients in a variety of ambulatory care settings, which is supported by published evidence of improved clinical and economic outcomes. Optimizing safe medication use. While the studies highlighted above certainly bolster the profession, much effort remains in order to realize the full potential of ambulatory care pharmacy practice. Preventable medication errors are still too prevalent and often result in patient injury and added costs, which has prompted several national initiatives from the IOM. A recent report estimated national annual costs associated with preventable ADEs in the ambulatory care setting at $887 million, equating roughly to $1,983 per ADE. 31 A study by
Raebel and colleagues at KPCO provided evidence supporting an ambulatory care pharmacist intervention to reduce inappropriate prescribing in elderly patients (65 or older) using a computerized medication safety alert. 32 Gandhi et al. found that ADEs occurred in roughly 27%
of patients in the ambulatory care setting (i.e., four times higher than that estimated for hospitalized patients), of which 39% were deemed preventable. 33 Furthermore, nearly two-thirds of the preventable ADEs were reported by patients as ADE-related symptoms to physicians but not acted upon during the three-month study period. Collectively, these reports point to the need and value of expanded ambulatory care pharmacy practices.
Optimizing diabetes care. As of 2011, an estimated 18.8 million patients of all ages were diagnosed with diabetes mellitus (DM); moreover, the incidence of DM and related complications is increasing. 34 Despite widespread availability of affordable evidence-based pharmacotherapy, many patients with DM still do not receive therapies that are clearly indicated.
Ambulatory care pharmacists have used population-based strategies as well as case management to address this therapeutic gap.
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Optimizing asthma care. Asthma affects an estimated 25 million people (approximately 1 in 12) in the United States. 37 In 2010, there were 15.5 million outpatient asthma-related visits to physicians' offices and hospital outpatient departments and 1.8 million visits to emergency departments. Without effective management, acute exacerbations are more frequent, and these require urgent treatment and result in $56 billion in medical costs, lost school and work days, and premature deaths according to 2007 data. 37 An Asheville project (apart from the project on management of diabetes) demonstrated an association between pharmacist-provided asthma education and long-term medication management services with improved clinical outcomes and reduced overall costs of care (despite increased cost of medications). 38 This report supports expanded roles for ambulatory care pharmacists to assist patients in the use of asthma medications and devices.
Optimizing cardiovascular disease care. Cardiovascular disease remains the leading cause of death in the United States with approximately 600,000 people perishing from heart disease (roughly 1 in 4 deaths). The economic burden of coronary heart disease in the U.S. is $108 billion annually, including costs of health care services, medications, and lost productivity. 39 Because medications are a mainstay of treatment for hypertension (HTN), dyslipidemia, arrhythmias, angina, heart failure, thromboembolism, and primary or secondary prevention of cardiovascular disease (e.g., coronary artery disease, myocardial infarction, and stroke), ambulatory care clinical pharmacy specialists have important opportunities to assist patients in achieving optimal medication and health outcomes, including reduced mortality related to cardiovascular disease, antithrombotic-related hemorrhage, and thromboembolism.
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Optimizing renal disease care. The primary causes of chronic renal disease are HTN and diabetes, based on 2006 data. 42 More than 20 million Americans have chronic renal disease, with at least as many at increased risk for developing the disease. 42 Adherence to complex medication regimens is crucial to stabilizing renal disease processes and slowing the progression of renal disease and comorbidities. Ambulatory care pharmacist specialists contribute significantly to prevention and management of chronic renal disease and end-stage renal disease through both case-based 43 and population-based 44 approaches.
Optimizing preventive care. As cited in the Healthy People 2020 report, 45 preventive clinical interventions such as immunizations and tobacco cessation improve economic and health outcomes. Among the national health objectives expressed in Healthy People 2020 is "prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases." 45 Ambulatory care pharmacists are now routinely acquiring specialized knowledge and training to screen patients and administer vaccines in nearly all states and across a variety of settings. 46, 47 Approximately 50 million adults in the United States smoke cigarettes, which ultimately will result in disability and premature death for half of them. For individuals who quit smoking, the risk of tobacco-related morbidity declines and eventually is similar to that of a nonsmoker, which reinforces the importance of tobacco cessation efforts. 48 Ambulatory care pharmacists provide access and care for patients and are appropriately positioned to implement evidence-based tobacco cessation treatments.
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Implementing precision therapeutics. Implementation of clinically relevant pharmacogenetic testing has been widely touted as the next frontier for individualizing pharmacotherapy for patients. 51, 52 Despite compelling models demonstrating the potential impact coordination, reduced medication-related problems, and associated mortality improvements. 54, 55 In addition, development of collaborative drug therapy management (CDTM) protocols, clinical practice guidelines, and thoughtful medication formularies will further facilitate an expansion of MTM to more ambulatory care health settings. Finally, pioneering work in establishment of MTM Current Procedural Terminology (CPT) payment codes paves the way for reimbursement of MTM services.
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Mitigating health care disparities. Significant health care disparities result from limited access to care, further highlighting the need for expanded ambulatory care pharmacy services.
The reports highlighted above demonstrate the ability of ambulatory care pharmacists to engage directly with patients and improve health care access. 
Opportunities created by national health care reform
In response to serious national health care problems related to access, cost, and quality, health care leaders are pursuing solutions, especially in chronic disease management, prevention, and optimal use of medications, 59 creating more opportunities for ambulatory care pharmacists.
An important facet of health care reform is a shift in payment structure from fee-for-service to pay-for-outcomes (or bundled, value-based payment). National and state governments and employer groups are fostering payment models that incentivize improved outcomes, lowed costs, increased access to care. Embodied within these objectives are greater accountability among providers and patients and implementation of innovative health care and technology solutions.
Patient care by ambulatory care pharmacists is aligned with a pay-for-outcomes model, as demonstrated by the evidence of the value of pharmacist interventions that increase quality of care and decrease health care costs.
Imperative for interprofessional team-based care
There is a vital need to continue to establish high-performance interprofessional teams that include ambulatory care pharmacists within accountable care organizations (ACOs) and patient-centered medical homes (PCMHs). 59 The changes needed to shift ambulatory care away from physician-centered care delivery toward interprofessional team-based care will not happen overnight. While interprofessional team-based care is central to patient-centered care, it is unreasonable to expect health professionals with different training, perspectives, and experiences to simply coalesce without a concerted multilevel initiative.
Shifting from "incidental" teamwork exposure to "deliberate and strategic" training as interprofessional teams, at both undergraduate and postgraduate levels, is imperative. It is essential to continue building and refining interprofessional programs in undergraduate and postgraduate pharmacy education to prepare practitioners who are "team-ready" to focus on optimizing patient care in ambulatory care settings.
Assisting health care providers through expanded scope of practice Figure 1 illustrates how the time demands on primary care physicians exceed the available hours. 60 Caring for 2,500 patients with the five most common chronic conditions would require a physician who works alone 6.7 hours per day. An additional 7.4 hours per day would be required to provide the panel of patients with important preventive services, especially those strongly recommended by the U.S. Preventive Services Task Force at Level A or B evidence. 61 Added to that would be 4.6 hours required to care for acute problems. Hence, to adequately care for a panel size of 2,500 patients, a primary care physician must work 18.7 hours a day, not including time required for phone calls, medication refills, charting, and other administrative tasks.
A number of projects have demonstrated that many patient visits to primary care providers, especially for chronic disease management, involve issues that could be handled by ambulatory care pharmacists via CDTM protocols. 62 Many patient care and care-coordination activities are more optimally provided by pharmacist members of a care team. 63 Consider the following examples:
• Most physicians deliver only 55% of recommended care, and 42% report not having enough time with their patients. 64 • Development of clinical pathways within ambulatory care pharmacies that streamline approval of medication refills by CDTM protocol frees up physician time for direct patient care. 65 • Providers spend 13% of their day on care coordination administrative activities and only half of their time on activities using their medical knowledge. Use of coordinated telepharmacy services that provide MTM and medication reconciliations during transitions of care effectively reduces this burden. 66 These examples indicate how ambulatory care pharmacists who practice at the top of their license can save physician time, optimize physician skills, improve access to care, and enhance clinical and economic outcomes.
Defining the scope of ambulatory care pharmacy practice
Providing comprehensive medication management for patients is a primary responsibility of ambulatory care pharmacists. This responsibility becomes even more important when considering the medication-related problems of the growing U.S. elderly population and the trend toward managing more acute conditions and acute exacerbations of chronic conditions in ambulatory care settings.
Physicians are increasingly drawn into specialty and subspecialty practices rather than primary care. 67 There is already a dearth of primary care physicians in the United States, and the prospect of expanding the shortage troubles many health care leaders. Ambulatory care
pharmacists have an opportunity to offset some of the anticipated deficit in the primary care work force. Parallel with the imperative for pharmacists to transition into a larger role in ambulatory care is the need for updated competency and practice standards tied to existing credentialing and certification pathways. As discussed in the next section of this paper, the current system of postgraduate pharmacy education provides a good foundation for enhancing the preparation of ambulatory care pharmacists for both generalist and specialist practice.
In 71, 72 Now is the time for the pharmacy profession to "lean into provider status, to establish a credentialing process in all pharmacy environments so we can make direct patient care services essential health care services for all our patients."
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Conclusion
"If you build it, he will come." In the popular 1989 movie Field of Dreams, a cornfield counseled character Ray Kinsella (played by Kevin Costner) to build a baseball diamond on his farm. In some ways the pharmacy profession faces a similar premise: Our dream will not come true unless we build it.
Ambulatory care pharmacists serve their patients, community, and society through a harmonious array of functions. These functions begin and end with competent, compassionate, patient-centered care provided by community pharmacists, institutional-based ambulatory care
pharmacists, and ambulatory care clinical pharmacy specialists. Depending on the needs of the patient and the resources required, the ambulatory care pharmacist provides medication management as an integral part of an interprofessional team-based care symphony. This is a crucible moment for the pharmacy profession. To meet the test of this moment, we must seek out higher levels of certification for our practice sites and ourselves. We must embrace documentation in a way that speaks the language of other health care providers and payers.
We must continue to demonstrate our value on nationally recognized metrics, as these are the basis for how other health care providers and health systems are rated, compared, and paid.
This is the way we will optimally assist physicians and health systems to earn support for provider status and payment for patient care services. Now is the time for ambulatory care pharmacy to lengthen its stride 74 and remember the wisdom of legendary coach John Wooden: 
